Enhanced dissolution and oral bioavailability of praziquantel by emulsification with human serum albumin followed by spray drying

Keishi Yamasaki, Kazuaki Taguchi, Koji Nishi, Masaki Otagiri, Hakaru Seo

Research output: Contribution to journalArticle


The goal of this study was to enhance the oral bioavailability of praziquantel through its conjugation with human serum albumin (HSA). Praziquantel-HSA particles were produced by spray drying an emulsion of an aqueous solution of HSA and a solution of praziquantel in oil. The particles were agglomerates of multiple smooth corrugated particles containing amorphous praziquantel nearly equivalent to the theoretical doses. The solubility of praziquantel in an aqueous medium was enhanced in both the produced particles and the physical mixture. In addition, the dissolution rate in an aqueous medium was enhanced in the case of particles, but not in a physical mixture. Thus, the inclusion of HSA by emulsification followed by spray drying appeared to contribute to the enhanced dissolution rate. In a pharmacokinetic study, the maximum plasma concentration (Cmax) and the area under the concentration-time curve (AUC) for the produced particles (HSA/praziquantel = 1/1 w/w) were approximately two times higher than the corresponding values for raw praziquantel. This increased oral bioavailability of the particles was considered to be due to the enhanced dissolution rate. This process for producing praziquantel-HSA particles could be useful in terms of improving the oral bioavailability of the other hydrophobic drugs.

Original languageEnglish
Article number105064
JournalEuropean Journal of Pharmaceutical Sciences
Publication statusPublished - 2019 Nov 1



  • Bioavailability
  • Dissolution
  • Emulsion
  • Human serum albumin
  • Praziquantel
  • Spray dry

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this